serw-MX  [xml]  

 DeCS Categories

D02 Organic Chemicals .
D02.065 Amides .
D02.065.199 Anilides .
D02.065.199.385 Encainide .
D02.092 Amines .
D02.092.146 Aniline Compounds .
D02.092.146.113 Anilides .
D02. Encainide .
D12 Amino Acids, Peptides, and Proteins .
D12.776 Proteins .
D12.776.157 Carrier Proteins .
D12.776.157.530 Membrane Transport Proteins .
D12.776.157.530.400 Ion Channels .
D12.776.157.530.400.875 Sodium Channels .
D12.776.157.530.400.875.750 Voltage-Gated Sodium Channels .
D12.776.543 Membrane Proteins .
D12.776.543.550 Membrane Glycoproteins .
D12.776.543.550.450 Ion Channels .
D12.776.543.550.450.875 Sodium Channels .
D12.776.543.550.450.875.750 Voltage-Gated Sodium Channels .
D12.776.543.585 Membrane Transport Proteins .
D12.776.543.585.400 Ion Channels .
D12.776.543.585.400.875 Sodium Channels .
D12.776.543.585.400.875.750 Voltage-Gated Sodium Channels .
D12.776.631 Nerve Tissue Proteins .
D12.776.631.960 Voltage-Gated Sodium Channels .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.519 Molecular Mechanisms of Pharmacological Action .
D27.505.519.562 Membrane Transport Modulators .
D27.505.519.562.750 Sodium Channel Blockers .
D27.505.519.562.750.500 Voltage-Gated Sodium Channel Blockers .
D27.505.954 Therapeutic Uses .
D27.505.954.411 Cardiovascular Agents .
D27.505.954.411.097 Anti-Arrhythmia Agents .
D27.505.954.411.720 Sodium Channel Blockers .
D27.505.954.411.720.500 Voltage-Gated Sodium Channel Blockers .
 Synonyms & Historicals
Encainide .
Encainide Hydrochloride .
Encainide Hydrochloride, (+-)-Isomer .
Encainide, (+)-Isomer .
Encainide, (-)-Isomer .
Enkaid .
MJ-9067 .
MJ 9067 .
MJ9067 .
One of the ANTI-ARRHYTHMIA AGENTS, it blocks VOLTAGE-GATED SODIUM CHANNELS and slows conduction within the His-Purkinje system and MYOCARDIUM. .
Anti-Arrhythmia Agents .
Anti-Arrhythmia Drugs .
Anti-Arrhythmics .
Antiarrhythmia Agents .
Antiarrhythmia Drugs .
Antiarrhythmic Drugs .
Agents, Anti-Arrhythmia .
Agents, Antiarrhythmia .
Agents, Antifibrillatory .
Anti Arrhythmia Agents .
Anti Arrhythmia Drugs .
Anti Arrhythmics .
Depressants, Cardiac .
Depressants, Myocardial .
Drugs, Anti-Arrhythmia .
Drugs, Antiarrhythmia .
Drugs, Antiarrhythmic .
Antifibrillatory Agents .
Cardiac Depressants .
Myocardial Depressants .
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. .
Voltage-Gated Sodium Channels .
Sodium Channels, Voltage-Gated .
Channels, Voltage-Gated Sodium .
Sodium Channels, Voltage Gated .
Voltage Gated Sodium Channels .
A family of membrane proteins that selectively conduct SODIUM ions due to changes in the TRANSMEMBRANE POTENTIAL DIFFERENCE. They typically have a multimeric structure with a core alpha subunit that defines the sodium channel subtype and several beta subunits that modulate sodium channel activity. .
Voltage-Gated Sodium Channel Blockers .
Channel Blockers, Voltage-Gated Sodium .
Voltage-Gated Sodium Channel Antagonists .
Voltage-Gated Sodium Channel Inhibitors .
Channel Blockers, Voltage Gated Sodium .
Voltage Gated Sodium Channel Antagonists .
Voltage Gated Sodium Channel Blockers .
Voltage Gated Sodium Channel Inhibitors .
A class of drugs that inhibit the activation of VOLTAGE-GATED SODIUM CHANNELS. .